Get in touch Contact us
Search Spire
Please type into the search bar above to begin your search
Please type three or more characters above to begin your search
Mr Philip Alexander

Practising at

Spire Cambridge Lea Hospital
View availability

Clinic times

Monday: 2.30pm - 4.30pm
Wednesday: 1.30pm - 6pm
Thursday: 8am - 12.30pm

An initial consultation with Mr Philip Alexander is from £250.

Mr Philip Alexander

Mr Philip Alexander

Consultant Ophthalmic Surgeon

BSc, MBBS, MBA, DIC, DM, FRCOphth

"Outstanding facilities, exceptional staff."

Specialises in

  • Cataract surgery
  • Diabetic eye disease
  • Retinal detachment

Also available for:

Virtual consultations:

Make an enquiry View availability

I have been a Consultant Ophthalmic Surgeon (eye surgeon) specialising in cataract surgery and vitreoretinal surgery, since 2016. I work at Addenbrooke’s Hospital (Cambridge University Hospitals) and also in private practice. 

I graduated as a doctor in 2002 with a double distinction and multiple academic prizes. After completion of my ophthalmology training, I had further advanced subspecialty surgical training in Southampton and Moorfields Eye Hospital. 

I've had the privilege of teaching cataract surgery to ophthalmologists on the East of England Training Programme. I also mentor a vitreoretinal surgical fellow to develop advanced surgical skills.

I am an Affiliated Associate Professor at the University of Cambridge and I teach (“supervise”) neuroscience to second year medical students.

I have 20 years of experience treating people with eye problems, and I have performed several thousand cataract operations and vitrectomy procedures. My surgical success rates are extremely high (99.58%) and are available online via nodaudit.org.uk.

My aim is to deliver personalised care for my patients, with the latest technology, to ensure the best possible outcomes. 

Read more...

General Medical Council Number: C6056731

Treatment information

Some of the principal treatments carried out by Mr Philip Alexander at Spire include:

Ophthalmology

Other treatments

  • Cataract surgery
  • Diabetic eye disease
  • Epiretinal membrane
  • Floater
  • Macular hole
  • Posterior capsular opacification following cataract surgery
  • Retinal detachment
  • Vitreomacular traction
  • Vitreous haemorrhage

Get in touch

88935
True
consultant
Marketing Information

Spire would like to provide you with marketing information about products and services offered by Spire and by selected third-party partners. If you do not consent for us to process your personal data for marketing activities, we will still be able to contact you about your enquiry.

We may contact you by email, SMS or phone about your enquiry. If we try to contact you by phone (mobile and/or landline) and you are not available, we may leave you a voicemail message. We may also use your details to contact you about patient surveys we use for improving our service or monitoring outcomes, which are not a form of marketing.


Additional information

Cataract surgery
Retinal disease

• Posterior capsular opacification (PCO) requiring YAG laser capsulotomy • Macular hole • Epiretinal membrane • Vitreomacular traction • Floaters / posterior vitreous detachment • Retinal tears / Retinal Detachment • Dislocated lens implants

MBBS (Distinction) / University of London / 2002
Bachelor of Medicine, Bachelor of Surgery

Professional memberships

Fellow of the Royal College of Ophthalmologists

He has over 45 publications in the scientific literature, and in 2013 was awarded funding from the Global Ophthalmology Awards Programme (GOAP) to conduct research into ocular stem cell transplantation, for which he later received a doctorate. He has presented his work at national and international meetings, and at the Houses of Parliament.

Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust.

Co-Founder and CEO of VisusNano Ltd, a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. This novel medical device will improve patient outcomes, and zliminate the need for eye drops after surgery. VisusNano Ltd has won several awards, including Oxford Biostars 2016.